California’s Anti-Smoking Push Spurs Big Savings on Health Costs
For the past 30 years, the California Tobacco Control Program has helped Californians save $816 billion in health care costs.
![A graphic illustration of a pack of cigarettes](/sites/default/files/styles/news_card__image/public/2023-03/cigarette-pack-card.jpg)
University of California San Francisco
Give to UCSFFor the past 30 years, the California Tobacco Control Program has helped Californians save $816 billion in health care costs.
In a first, UCSF scientists created a molecular-level, 3D picture of how an odor molecule activates a human odorant receptor.
A new digital tool helps to calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
Sick leave coverage expansion were associated with higher rates of mammography screening and colorectal screening, potentially leading to better health outcomes.
A sexual health strategy called Doxy-PEP, which involves taking doxycycline after condomless sex, is highly effective in reducing bacterial STIs but is still associated with a limited rise in resistant strains of bacteria.
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
Emily Goldberg's lab studies what happens during aging to a particular set of immune cells: those embedded in fat tissue. She hypothesizes that changes to these cells during aging could be key to age-related inflammation.
Sneddon is trying to coax stem cells into reliably developing functional beta cells that can then be transplanted into patients with diabetes so that they can produce their own insulin.
Angela Phillips, PhD, leads research that could help predict future viruses like COVID and the antibodies we might use to treat them.
Leanne Jones, PhD, is at the forefront of studying how stem cells are influenced by their surrounding environment and directed to differentiate into one type of cell or another – research that’s critical for stem cell therapies to be successful.
Because proteins can adapt to extremes, Margaux Pinney, PhD, believes they can show how living organisms might adapt to climate change.
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
Vissers’ work on RNA tags helped found the field of epitranscriptomics, the study of how chemical marks on RNA, rather than their sequence alone, dictate the function of the molecules.
Faranak Fattahi’s lab is a national leader in growing stem cells to model peripheral nerves, focusing on gastrointestinal diseases.
Shaeri Mukherjee, PhD, has won the Bowes Biomedical Investigator award, which will provide funding to further her work using bacterial pathogens to identify basic processes inside human cells.
A new digital tool helps calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
Diane Havlir, MD, UCSF’s Weiss Professor, an AIDS pioneer, and an infectious disease leader, is partnering with the local Latinx community to protect vulnerable San Franciscans from COVID-19 and other diseases.
With vaping taking over the youth market, Pamela Ling, MD ’96, MPH, applies her research-driven social media and marketing expertise to beat the tobacco industry at its own game.
Trillions of invisible organisms make up the human microbiome. Now, medical scientists want to put these bugs to work.
On the operating table and inside the lab of a rising star in cancer neurosurgery.
Resecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.